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Abstract
 
Natural killer cells constitute 50–90% of lymphocytes in human uterine decidua in early preg-
nancy. Here, CD56
 
bright
 
 uterine decidual NK (dNK) cells were compared with the CD56
 
bright
 
and CD56
 
dim
 
 peripheral NK cell subsets by microarray analysis, with verification of results by
flow cytometry and RT-PCR. Among the 
 
 
 
10,000 genes studied, 278 genes showed at least a
threefold change with P 
 
 
 
 0.001 when comparing the dNK and peripheral NK cell subsets,
most displaying increased expression in dNK cells. The largest number of these encoded surface
proteins, including the unusual lectinlike receptors NKG2E and Ly-49L, several killer cell Ig-
like receptors, the integrin subunits 
 
 
 
D
 
, 
 
 
 
X
 
, 
 
 
 
1, and 
 
 
 
5, and multiple tetraspanins (CD9,
CD151, CD53, CD63, and TSPAN-5). Additionally, two secreted proteins, galectin-1 and
progestagen-associated protein 14, known to have immunomodulatory functions, were selec-
tively expressed in dNK cells.
Key words: pregnancy • maternal-fetal relations • natural killer cells • gene expression proﬁling • 
lymphocyte subsets
 
Introduction
 
In pregnancy, hemiallogeneic fetal cells invade the maternal
 
decidua but remain spared from attack by the maternal
immune system, posing a great unsolved paradox of immu-
nology (1). Although several factors have been proposed
to explain or contribute to maternal tolerance, our under-
standing of the immunobiology of normal pregnancy and
its implications for pregnancy-related pathologies is still
limited (2). One prominent feature of the pregnant human
decidua is the striking abundance of NK cells, which
 
constitute 
 
 
 
70% of resident lymphocytes (3). In contrast,
NK cells in peripheral blood comprise 
 
 
 
15% of circulating
lymphocytes (4). Thus, human uterine decidual NK
(dNK) cells have been thought to play a role in implanta-
tion and pregnancy, at least in early gestation. Although
the precise functions of dNK cells in vivo are still un-
known, their proximity to the invading trophoblasts,
which lack expression of classical HLA-A and -B antigens
(5) but selectively express HLA-C and the nonclassical
HLA-E, -G, and CD1d molecules (6–9), has led to the
proposal that these MHC antigens on trophoblasts interact
with NK cell receptors (3, 10). Human NK cell receptors
include the C-type lectinlike NKG2 receptors that asso-
ciate with CD94 and the killer cell Ig-like receptors
(KIRs), each of which have both inhibitory and activating
isoforms that depend on the presence of immunoreceptor
tyrosine-based inhibitory motifs (ITIMs) in their cyto-
plasmic tails or immunoreceptor tyrosine-based activating
motifs in associated molecules, such as DAP12. More-
over, the KIR locus is polygenic and polymorphic, giving
rise to variable KIR repertoires that are expressed on sub-
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sets of NK cells among individuals. However, it is still
unclear if and which receptors on dNK cells interact with
trophoblast-expressed HLA molecules, and whether such
interactions inhibit NK cell lysis, or lead to production of
cytokines that favor normal placental development and
maintenance of pregnancy (11). Moreover, the interac-
tions between NK cell receptors and their ligands have
been investigated mostly on peripheral blood NK (pNK)
cells, but the relationship between dNK and pNK cells is
unclear.
pNK cells comprise two different subsets, the predomi-
nant CD56
 
dim
 
 NK cell subset and the much smaller
CD56
 
bright
 
 NK cell subset, constituting 
 
 
 
95 and 5% of
pNK cells, respectively (4). CD56
 
dim
 
 pNK cells express
high levels of CD16 and both CD94-associated lectinlike
NKG2 receptors and KIRs, are granular, and known to
be cytotoxic. In contrast, CD56
 
bright
 
 pNK cells are mostly
devoid of granules, CD16, and KIRs, but express higher
amounts of other markers (12–15), such as CD94 (16)
and L-selectin (17). Recent papers demonstrate greater
cytokine production capacity of CD56
 
bright
 
 than CD56
 
dim
 
pNK cells and, thus, suggest an immunoregulatory role
for the CD56
 
bright
 
 pNK subset (18, 19). The resemblance
of dNK cells to the CD56
 
bright
 
 pNK subset, at least in
terms of their CD56
 
bright
 
 CD16
 
neg
 
 phenotype, has sug-
gested that dNK cells are derived from CD56
 
bright
 
 pNK
cells that are seeded in the uterus and undergo further dif-
ferentiation in the decidual microenvironment. For in-
stance, they both exhibit low cytotoxicity against the NK
cell target K562 (20), and contain cytoplasmic CD3
 
 
 
mRNA (21), in contrast to CD56
 
dim
 
 pNK cells. On the
other hand, like CD56
 
dim
 
 pNK, dNK cells are granulated
and express KIRs (22, 23). Yet, other properties seem
unique to dNK cells, such as the expression of the activa-
tion marker CD69 (24) and the absence of L-selectin
(25). Despite some additional characterization of pheno-
typic and functional differences between dNK and pNK
cells (26), a comprehensive comparison of dNK cells in
relation to both CD56
 
bright
 
 and CD56
 
dim
 
 pNK cell subsets
is lacking.
In this work, patterns of gene expression in freshly iso-
lated CD56
 
bright
 
 pNK, CD56
 
dim
 
 pNK, and dNK cells were
compared using oligonucleotide microarrays. The tran-
scriptional profiles provide detailed information on the
differences between dNK and pNK cells, as well as be-
tween the peripheral CD56
 
dim
 
 and CD56
 
bright
 
 subsets. Us-
ing a stringent statistical approach, a large number of dif-
ferentially expressed genes (197) were identified between
dNK and pNK cells, whereas only 
 
 
 
40 genes distin-
guished the two subsets of pNK cells from each other.
Multiple genes were expressed in dNK cells whose tran-
scripts were completely absent in pNK cells. A number of
differentially expressed genes/proteins were validated by
RT-PCR or flow cytometry. Several genes differentially
and/or uniquely expressed in dNK cells encode proteins
that are likely to be involved in maternal-fetal tolerance
and provide potential critical targets for further study of
dNK cells.
 
Materials and Methods
 
Samples 
 
Decidual samples from patients undergoing elective abortion in
the first trimester between 6 and 12 wk of gestation were collected
at the New York University Medical Center. Decidual tissue was
washed extensively in PBS supplemented with 50 
 
 
 
g/ml genta-
micin before mincing with sterile scissors. Decidual lymphocytes
were released by digesting the tissue with 0.1% collagenase type
IV and 0.01% DNase I (both from Sigma-Aldrich) in RPMI 1640
medium for 30 min at 37
 
 
 
C. Decidual stromal cells and macro-
phages were allowed to adhere to tissue culture plates for 2 h at
37
 
 
 
C in a humidified 5% CO
 
2
 
 incubator. Lymphocytes from the
overlaying solution were subsequently purified by density gradi-
ent centrifugation (Ficoll-Hypaque; Amersham Biosciences) and
used for flow cytometric staining and cell sorting. Peripheral
blood lymphocytes were isolated from peripheral blood from
anonymous healthy donors using Ficoll either directly or after en-
richment for NK cells using Rosettesep according to the manu-
facturer’s instructions (StemCell Technologies Inc.).
 
Flow Cytometry 
 
The following murine mAbs, purified or directly conjugated
with FITC, PE, or Cychrome, were used in FACS
 
®
 
 analysis:
anti-CD3, anti-CD56, anti-CD16, anti-CD9, anti-KIR2DL1/S1
(CD158a; EB6), anti-KIR2DL2/2DS2/2DL3 (CD158b; GL183),
and anti-KIR3DL1 (CD158e; NKB1), which were all from BD
Biosciences; anti-CD62L (DakoCytomation); anti-KIR2DL4
(KIR2DL4-specific mAbs 33, 36, and 64, supplied by E. Long
[National Institutes of Health, Bethesda, MD; reference 27]),
and IgG and IgM isotype controls (BD Biosciences). Secondary
anti–mouse Ig fluorochrome conjugates used were goat F(ab
 
 
 
)2
anti–mouse IgG-FITC, goat F(ab
 
 
 
)2 anti–mouse IgG 
 
 
 
 IgM-
FITC, and goat anti–mouse IgG-PE (Caltag). For FACS
 
®
 
 stain-
ing and sorting, cells were washed in PBS supplemented with 2%
FCS and incubated with mAb on ice for 30 min, followed by
washing twice with PBS, pH 7.2, and 2% FCS. Cell sorting and
fluorescence measurements were performed on a MoFLo high
performance cell sorter (DakoCytomation). For fluorescence
measurements only, data from 10,000 to 50,000 single cell events
were collected using a standard FACScalibur™ flow cytometer
(Immunocytometry Systems; Becton Dickinson). Data were
analyzed using CELLQuest™ (Becton Dickinson) or Flow Jo
(Treestar).
 
Preparation of Labeled RNA and Microarray Hybridization 
 
Flow-sorted cells were washed with PBS, and the cell pellets
were frozen in TRIzol (GIBCO BRL). Total RNA was isolated
according to the TRIzol manufacturer’s instructions, with addi-
tion of 5 
 
 
 
g linear polyacrylamide (Genelute LPA; Sigma-
Aldrich) to aid visualization of RNA pellets. RNA was subjected
to the clean-up protocol as per the manufacturer’s instructions
(Rneasy mini RNA isolation kit; QIAGEN). The subsequent
RNA amplification and clean-up protocol was adapted from
Baugh et al. (28). Biotinylated cRNA was hybridized to human
genome HGU95Av2 chips displaying probes for 
 
 
 
10,000 full-
length genes for expression analysis. Chips were processed ac-
cording to manufacturer’s instructions (for further experimental
details see 
 
Online Supplemental Material
 
). Gene transcript levels
were determined using algorithms in the Microarray Suite 5.0
software (Affymetrix, Inc.). Based on Affymetrix, Inc. decision
matrices, each probe was assigned a call of present (expressed) or
absent (not expressed). 19 samples out of 22 samples were of suf-T
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ficient quality to be further analyzed (nine dNK, five CD56
 
bright
 
pNK, and five CD56
 
dim
 
 pNK cells; Table SI available at http://
www.jem.org/cgi/content/full/jem.20030305/DC1).
 
Microarray Data Analysis 
 
Sample Clustering. 
 
Sample clustering analysis was performed
with D-chip software (http://www.dchip.org). Intensity values
were normalized by the model-based expression analysis method
(29). Genes with variable expression levels across the 19 samples
were selected by applying two criteria as follows: genes should be
expressed (have presence calls) in at least 20% of the 19 samples,
and 
 
 
 
i
 
/
 
 
 
i
 
 ratio should be 
 
 
 
0.5 and 
 
 
 
25, where 
 
 
 
i
 
 and 
 
 
 
i
 
 are the
standard deviation and mean of the hybridization intensity values
of each particular gene across all samples, respectively. An unsu-
pervised hierarchical clustering algorithm (30) was applied to
group the 19 samples based on the similarity of the expression
profiles of the selected genes.
 
Student’s T Test Comparisons and Identification of Differentially
Expressed Genes. 
 
The 19 samples were normalized by setting a
trimmed mean (using middle 95% of the distribution) to be the
same; there were no noticeable problems with saturation or other
nonlinear effects. To reduce the number of genes for subsequent
analysis, a conservative requirement was applied that a gene must
be present (according to the Affymetrix, Inc. algorithm) in at least
5 of the 19 samples, given the smallest sample size of 5 in both
pNK cell groups.
Samples were grouped according to their biological origin in
dNK (nine samples), CD56
 
dim
 
 pNK (five samples), and CD56
 
bright
 
pNK cells (five samples). Three pairwise comparisons (dNK vs.
CD56
 
bright
 
 pNK, dNK vs. CD56
 
dim
 
 pNK, and CD56
 
bright
 
 pNK vs.
CD56
 
dim
 
 pNK) were performed to identify differentially ex-
pressed genes using the Student’s 
 
t
 
 test with unequal variances. At
P 
 
 
 
 0.01 (unadjusted for multiple testing), 
 
 
 
1,100 genes were
significantly differentially expressed in the pairwise comparisons
involving dNK cells, whereas 
 
 
 
300 were differentially expressed
in the CD56
 
bright
 
 pNK versus CD56
 
dim
 
 pNK cell comparison. To
rule out the possibility that this result was generated by the larger
sample size in the case of dNK (nine samples vs. five of each pNK
subset), the analysis was repeated with all possible sets of five sam-
ples from the nine original decidual samples. Although the total
number of differentially expressed genes between all three subsets
was slightly less, the number of differentially expressed genes be-
tween dNK and pNK
 
bright
 
 or pNK
 
dim
 
 cells was still nearly three
times the number of such genes between pNK
 
bright
 
 and pNK
 
dim
 
cells (Table SII available at http://www.jem.org/cgi/content/
full/jem.20030305/DC1).
278 genes showing at least a threefold change in transcript lev-
els at Student’s 
 
t
 
 test P 
 
 
 
 0.001 in at least one of the three pair-
wise comparisons were considered for further analysis. For genes
represented by multiple probesets, the result for only one repre-
sentative probeset is shown. Genes were classified, based on in-
formation available on the worldwide web (see 
 
Online Supple-
mental Material
 
).
For Venn diagrams, genes were considered to be up-regulated
in a particular NK subset if they showed a significant fold increase
(P 
 
 
 
 0.001) in at least one of the Student’s 
 
t
 
 test comparisons in-
volving that particular subset. Venn diagrams were constructed by
intersecting the set of genes considered up-regulated in each of
the three NK cell groups.
 
RT-PCR. 
 
RT-PCR was performed using equal amounts of
RNA available from three dNK cell samples and CD56
 
dim
 
 and
CD56
 
bright
 
 pNK cells. First strand cDNA was synthesized from
300 ng total RNA using Superscript II Reverse transcriptase for
RT-PCR, according to the manufacturer’s protocol (Life Tech-
nologies). PCR was done with 2 
 
 
 
l cDNA template in a total
volume of 50 
 
 
 
l containing 1.5 mM MgCl
 
2
 
, 10 mM dNTP, 2U
Taq DNA polymerase, and 10 
 
 
 
M of each primer in 10
 
 
 
 PCR
buffer (Taq DNA polymerase PCR kit; QIAGEN). The PCR
reaction profile consisted of 1 min at 95
 
 
 
C, followed by 30 cycles
of 30 s at 94
 
 
 
C, 30 s at 60
 
 
 
C, and extension for 30 s at 72
 
 
 
C, with
a final 5-min extension at 72
 
 
 
C. 10 
 
 
 
l of each product was visual-
ized on 1–2% agarose gels. Primers used were as follows:
NKG2E-Fw (5
 
 
 
-AGAATTAAACCTTCAAAATGCTTCT-3
 
 
 
)
and NKG2E-Rev (5
 
 
 
-GATTCTTGAAGATCCACACTGGT-
3
 
 
 
) for specific amplification of a 553-bp NKG2E product;
NKG2C-Fw (5
 
 -GAAGAGAGTTTGCTGGCCTGTA-3 ) and
NKG2C-Rev (5 -CACTGGGCTGATTTAAGTCGAT-3 ) for
a 242-bp NKG2C product,   actin–Fw (5 -AACTGGGACGA-
CATGGAGAAAA-3 ) and   actin–Rev (5 -TCGGTGA-
GGATCTTCATGAGGT-3 ) for a 353-bp  -actin product;
progestagen-associated protein 14 ( PP14)/GdA-Fw (5 -AGA-
GCTCAGAGCCACCCAC-3 ) and PP14/GdA-Rev (5 -GTG-
GGAGTCTGGTCTTCC-3 ) for a 544-bp PP14/GdA; and
GAL1-Fw (5 -CCCACGGCGACGCCAAC-3 ) and GAL1-
Rev (5 -AGAGGCAGCTGCCTTTATTG-3 ) for a 295-bp ga-
lectin-1 product.
Online Supplemental Material. The supplemental material, data
sets, Tables S1 and S2, and Figs. S1 and S2 are available at http://
www.jem.org/cgi/content/full/jem.20030305/DC1. The sup-
plemental material provides further details about cRNA prepara-
tion and hybridization, and gene classification, as well as explana-
tory comments for supplemental microarray Data Sets 1–3. Table
S1 lists samples used for hybridization to genechips. Table S2
summarizes the number of differentially expressed genes in pair-
wise comparisons. Fig. S1 supplements Fig. 3. Fig. S2 shows
FACS® and RT-PCR results for relevant markers after applying
the procedure used for isolating dNK cells to pNK cells.
Results and Discussion
Comparison of Gene Expression in Human dNK and pNK 
Cells by Microarray Analysis
CD56bright dNK cells and the two subsets of pNK cells
(CD56bright and CD56dim) have been distinguished by only
a few differentially expressed surface markers (3). The
functional differences among them are still unclear. To
further characterize dNK cells in relation to pNK cells
and to discover genes with relative overexpression that
could provide clues to their function, the gene expression
profiles of freshly isolated NK cells from decidual and pe-
ripheral blood were compared. Cells obtained as described
in Materials and Methods were flow sorted as illustrated in
Fig. 1 A. The hybridization results, listing the number of
present calls, the average hybridization intensities, and stan-
dard deviations for each NK cell subset (nine dNK, five
CD56bright pNK, and five CD56dim pNK cell samples) and
all 12,558 probe sets are available in Data Set S1 (avail-
able at http://www.jem.org/cgi/content/full/jem.20030305/
DC1).
The 19 samples were organized on the basis of overall
similarity in their gene expression patterns by an unsuper-
vised hierarchical clustering algorithm of variable genes
(30). A dendrogram, in which the pattern and length of theT
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branches reflect the comparative difference in gene expres-
sion profiles between each of the dNK and pNK cell sam-
ples is shown in Fig. 1 B. dNK cells are clearly distinct
from both subsets of pNK cells, as illustrated by the length
of the two terminal branches. Within the group of pNK
cells, a secondary branching point separates the CD56bright
and CD56dim samples. At the transcriptional level, dNK
cells differ notably from both subsets of pNK cells and are
more distinct than the two peripheral CD56bright and
CD56dim subsets are from each other. In other words, the
two subsets of pNK cells are far more closely related to
each other than either is to dNK cells.
Pairwise Student’s t test comparisons of the hybridization
data with the three NK cell subsets using P   0.01 subse-
quently revealed differential expression of 1,785 genes,
most of which were found in the comparisons involving
dNK cells. Even after adjusting for the uneven sample sizes,
the number of genes differentially expressed between the
pNK subsets was about three times smaller (Table SII).
To reduce the number of differentially expressed genes
to a manageable number, genes with a fold change of
three or greater in at least one of the three pairwise com-
parisons at P   0.001 were considered. These stringent
criteria were met by 278 genes. An image of these genes
clustered by similar expression patterns is represented in
Fig. 1 C. Overall,  70% of the 278 differentially ex-
pressed genes were overexpressed in dNK cells (197
genes) as compared with either CD56bright or CD56dim
pNK cells, whereas roughly 30% of genes were overex-
pressed in pNK cells versus dNK cells, as illustrated by a
Venn diagram (Fig. 2 A). 
As an internal control, CD56, a prototypical NK cell
marker, was first considered. CD56 (NCAM-1) appeared
in the list of 278 genes, and revealed higher intensities in
dNK as compared with both pNK subsets. This was also
observed by FACS® analysis (Fig. 1 A and see Fig. 4 A).
CD16 identifies CD56dim NK cells and was absent in
CD56bright pNK and dNK cells (see Fig. 4 B). The latter re-
sult was foreseen because cell separation included CD16
expression as one parameter (Fig. 1 A). After classification
of the genes into functional categories, the largest number
of transcripts enriched in dNK cells were those encoding
Figure 1. dNK CD56bright, pNK CD56bright, and pNK CD56dim cells
represent three different NK cell subsets. (A) Typical gates used for flow
sorting dNK (red), pNK CD56bright CD16- (green), and CD56dim CD16-
(blue) NK cell subsets. Decidual and peripheral lymphocyte suspensions
were triple stained with directly conjugated mAbs reactive with CD3,
CD16, and CD56. Lymphocytes were first gated by forward scatter/side
scatter characteristics. After setting a gate on CD3 negative cells (NK-
enriched peripheral blood preparations were typically already  99%
CD3-negative), cells were sorted on the basis of CD56 and CD16 expression.
(B) Unsupervised hierarchical clustering of 19 freshly sorted NK cell samples
based on the expression profile of genes with variable expression levels
across all samples. The organization and length of the branches in the
resulting dendrogram reflect the similarity in gene expression profiles
between each of the samples. No correlation between gestational age
(range, 6–12 wk) and clustering pattern was observed. (C) Relative intensity
profiles of 278 genes differentially expressed with at least a threefold
change at P   0.001 in at least one of the three comparisons (dNK vs.
CD56bright pNK; dNK vs. CD56dim pNK; CD56bright vs. CD56dim pNK).
Each row represents relative hybridization intensities of a particular gene
across different samples. Each column represents one sample. Colors reflect
the magnitude of relative expression of a particular gene across samples.
Brighter red means higher expression, brighter green means lower expression,
and black means average intensity across samples.T
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membrane proteins (Fig. 2 B). Additionally, the 278 dif-
ferentially expressed genes are shown with fold changes
for each comparison in Fig. 3 (also see Fig. S1, available
at http://www.jem.org/cgi/content/full/jem.20030305/
DC1). Expression of several of these genes was examined
by either flow cytometry (Fig. 4) or RT-PCR (Fig. 5).
Membrane Proteins Overexpressed in dNK Cells
Tetraspanins and Integrin Subunits.  Among the 278 dif-
ferentially expressed genes, a large number of genes were
surface molecules and receptors (Fig. 2 B and Fig. 3 A).
Among the genes in this category, three members of the
transmembrane 4 superfamily (CD151, CD9, and tet-
raspan-5; also known as tetraspanins) were exclusively ex-
pressed in dNK cells. Two integrin subunits, the  D (IT-
GAD;CD11d) and the  5 (ITGB5) subunits were also
highly overexpressed by dNK. Other tetraspanins (CD53
and CD63) and integrin subunits ( 1 [ITGB1] and  x [IT-
GAX;CD11c]) were relatively overexpressed in dNK cells
in relation to at least one of the peripheral subsets. Integrins
are involved in cell–cell and cell–extracellular matrix inter-
actions and influence diverse processes such as cell adhe-
sion, migration, activation, and interaction with target cells.
Many of the tetraspanins may facilitate these processes by
assembling molecules into membrane clusters, distinct from
lipid rafts (e.g., by participating in functional signaling
complexes with other integrins, lineage-markers, or other
tetraspanins; references 31–36). The overexpression of sev-
eral of these proteins in dNK cells may be related to the
mechanisms used by dNK cells for migration to, retention
within, and/or their effector function within the pregnant
uterine mucosa. FACS® analysis confirmed surface expres-
sion of both CD9 and CD151. CD9 is exclusively ex-
pressed on dNK cells and emerges as a specific marker for
these cells ex vivo (Fig. 4, C and D).
Interestingly, a ligand for murine CD9, murine preg-
nancy-specific glycoprotein (PSG) 17, was recently identi-
fied (37). This prompts the interesting hypothesis that dNK
cells, through their CD9 receptor, may interact with pla-
cental PSGs and consequently produce cytokines that sup-
port successful pregnancy. PSGs are a family of highly sim-
ilar, placentally secreted proteins, originally isolated from
the circulation of pregnant women. In humans, PSG con-
centration in the bloodstream increases exponentially until
term (38) and low PSG levels are associated with recurrent
spontaneous abortions (39). Administration of anti-PSG
Abs induced spontaneous abortion in primates, indicating
that PSGs are essential for successful pregnancy (40). In ad-
dition, PSGs may induce production of antiinflammatory
cytokines by monocytes (41).
Lectinlike Receptors.  Of particular interest, NKG2C and
NKG2E genes both were highly significantly overex-
pressed in dNK cells. Both showed increased hybridization
in the three- to fivefold range (Fig. 3 A and Fig. 5). The
specificity of this result was confirmed by RT-PCR.
NKG2C and NKG2E are CD94-associated members of
the C-type lectin like receptors with presumed activat-
ing functions. The CD94/NKG2C heterodimer associates
with DAP12 and binds to HLA-E (42, 43). Although the
resemblance of NKG2E to NKG2C in terms of an ITIM-
lacking cytoplasmic domain (both containing a Lys residue
in the transmembrane region that may lead to association
with DAP12) suggests an activating function, the ligand
and functions of NKG2E have not been described previ-
ously (44). Moreover, detection of NKG2E protein has not
been reported.
The CD94-associated lectinlike inhibitory receptor
NKG2A, which bears two ITIMs in the cytoplasmic do-
main and for which the ligand is HLA-E, was not repre-
sented on the chip because the polymorphism and isoforms
of this gene makes it difficult to select specific probes. Its
expression on the three NK cell subsets in association with
CD94 was detected by FACS® analysis using the NKG2A-
Figure 2. The majority of differentially expressed genes are up-regulated
in dNK cells. (A) Venn diagram generated by the intersection of the list
of genes up-regulated by each NK cell subset. Genes were considered to
be overexpressed in a particular NK cell subset if they showed higher expres-
sion relative to at least one of the other subsets in the pairwise Student’s t
test comparisons at P   0.001. For example, a total of 197 genes are over-
expressed in dNK versus at least one of the two pNK subsets, 188 of
which were overexpressed in dNK only. Only 2 of the 197 genes are
overexpressed in both dNK and CD56bright pNK cells versus CD56dim
pNK cells (intersection of red and green), and 7 of the 197 genes are
overexpressed in dNK and CD56dim pNK cells versus CD56bright pNK
cells (intersection of red and blue). (B) Distribution by functional category of
genes with significant up-regulation in each NK cell type. I, surface mole-
cules/receptors/adhesion; II, chemokines/cytokines/immunomodulatory
and other secreted proteins; III, immune effector molecules and apoptosis
related; IV, signal transduction related; V, cytoskeleton related; VI, cell
cycle   stress; VII, DNA binding/transcription/translation; VIII, metabo-
lism; IX, other genes; and X, genes with unknown function.T
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Figure 3. Differentially expressed genes in dNK and pNK cells. Fold changes of genes that showed greater than or equal to threefold change. P   0.001
(black bars) in at least one of the three pairwise comparisons: dNK versus pNKbright (left diagrams); dNK versus pNKdim (middle diagrams); and pNKbright versus
pNKdim (right diagrams) are presented. The 278 transcripts that met these criteria were classified into the following 10 categories: I, surface molecules/receptors/
adhesion (A, 58 genes); II, chemokines/cytokines/immunomodulatory and other secreted proteins (B, 12 genes); III, immune effector molecules and apoptosis
related (C, 7 genes); IV, signal transduction related (32 genes); V, cytoskeleton related (26 genes); VI, cell cycle   stress (15 genes); VII, DNA- binding/T
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specific mAb Z199 and anti-CD94. CD94 was not differ-
entially expressed in the chip analyses (unpublished data).
The manner in which signals mediated through activating
and inhibitory receptors on the same cell are integrated re-
mains to be explored.
Ly-49L (Fig. 3 A, KLRA1) was present and overex-
transcription/translation (33 genes); VIII, metabolism (23 genes); IX, other genes (40 genes); and X, genes with unknown function (33 genes). The first three
categories are shown in this figure (A–C); data for the remaining categories are shown as Fig. S1. Black and gray bars represent fold changes in pairwise
comparisons with significance levels  0.001 and  0.05, respectively. White bars represent statistically nonsignificant changes. Gene, gene name, or gene
symbol obtained from Locuslink or Netaffx (Affymetrix, Inc.). GB, GenBank accession number. Probe ID, Affymetrix probeset designation. P-(Presence) calls
(dNK, bright, and dim), number of present calls by Affymetrix algorithms in nine dNK, five pNK CD56bright, and five CD56dim NK cells, respectively.
Figure 4. Verification of selected surface expressed molecules by flow cytometry. To compare protein expression on the different NK cell populations
(gated as in Fig. 1 A), triple or quadruple [CD56   CD16   (CD3)   (marker of interest) on NK-enriched peripheral blood preparations; CD56  
CD3   (CD16)   (marker of interest) on decidual samples] staining was performed. Histogram overlays (representative of at least five experiments) dem-
onstrating the expression of various markers are shown together with genechip hybridization intensity data (bars) for the probeset of the corresponding
gene. Gray and black histograms represent the isotype controls for pNK and dNK cells, respectively. Lines and bars are color-coded for dNK (red),
CD56bright pNK (green), and CD56dim pNK cells (blue). Numbers on bars represent number of “present” calls (according to Affymetrix, Inc. algorithms)
per number of samples hybridized. CD56 (a), CD16 (b), CD9 (c), CD151(d), KIR2DL3* (e), KIR3DL1** (f), and KIR2DL4 (g) were among the list of
278 differentially expressed genes fitting the stringent criteria (threefold change and P   0.001 in any of the comparisons). *KIR2DL3 was verified with
mAb CD158b, (reactive besides KIR2DL3, with KIR2DS3 and KIR2DL2/S2 that were not represented on the chip) **KIR3DL1 was verified with
mAb NKB1 (also reactive with KIR3DS1). CD62L (h), shown as an example of a gene differentially expressed in CD56bright pNK cells (17), was differ-
entially expressed resulting from pairwise Student’s t test comparisons at P   0.01, but did not fit the more stringent criteria of threefold change and P   0.001.
Levels of significance per comparison are indicated. NS, not significant.T
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pressed in nearly all of the dNK cells but absent from both
sets of pNK cells (Fig. 3 A, P-calls). This unusual transcript
is derived from a gene that encodes a member of the lectin
superfamily closely related to the large family of murine
Ly-49 genes. The single human gene has been found ex-
pressed only as transcripts that would lead to a truncated
protein, due to a single nucleotide substitution preceding a
splice donor site in Exon 5 (45, 46). However, the full-
length transcript was found in both baboons and the oran-
gutan (47, 48). It remains to be seen whether the full-
length transcript and the corresponding protein can be
produced in human materials, particularly in dNK cells,
and if so, what its function might be.
KIR Genes.  All of the KIR genes for which probes
were present on the genechip (KIR3DL1, KIR3DL2,
KIR2DL3, and KIR2DL4) were overexpressed by dNK
cells (Fig. 3 A). KIRs have been known to be expressed on
both dNK and CD56dim pNK cells, but not on CD56 bright
pNK cells. Staining for KIRs using the available mAbs
CD158a (unpublished data), CD158b, and NKB1 (Fig. 4,
E and F) consistently showed a much higher proportion of
positive cells in dNK cells than in CD56dim pNK cells, in
keeping with the increased transcript levels found on the
average in dNK cells. These data are in accordance with
previously published data on KIR expression in peripheral
and decidual blood from the same individual (22).
KIR2DL4 expression has been reported on both dNK
and pNK cells (49, 50). Although it has been suggested
that it is the HLA-G receptor, other recent data do not
support this conclusion (51, 52). The present findings in-
dicate that KIR2DL4 is transcribed in dNK cells to a
higher degree than in CD56dim or CD56bright pNK cells
(Fig. 3 A). Using anti-KIR2DL4–specific antibodies (27),
the surface expression of this receptor protein was found
in 5 out of 11 tested dNK cell samples, but was not detect-
able on pNK cells in 5 tested samples (Fig. 4 G). In con-
trast with many of the other KIRs that are variably present
in individual genomes, KIR2DL4 is found in all haplo-
types. Yet, a single base deletion in the KIR2DL4 gene,
which predicts generation of a molecule with a shortened
cytoplasmic tail (53) and possibly a protein which is ulti-
mately not surface expressed, occurs. A considerable num-
ber of individuals are homozygous for this deletion (54),
which may partly explain the lack of reactivity seen with
the anti-KIR2DL4 mAb.
Figure 5. Confirmation of transcript expression by RT-PCR analysis.
RT-PCR was performed on total RNA isolated from human dNK,
CD56dim, and CD56bright pNK cells. Results shown are representative of
three different samples for each of these NK cell types (right). Genechip
hybridization data for the 19 samples and statistical significance levels of
pairwise comparisons are presented (left). Numbers on bars represent
number of present calls (according to Affymetrix, Inc. algorithms) per
number of samples hybridized to genechips. Fold changes and levels of
significance per comparison are indicated. NS, not significant. Specific
transcripts for NKG2C, NKG2E, galectin-1, and PP14 were detected in
dNK cell samples by RT-PCR, whereas their presence appeared to be
relatively less (or absent in the case of PP14) in both pNK cells subsets. In
the genechip experiments, these transcripts were found to be overexpressed
in dNK cells with fold differences, 3- to 9-fold (NKG2s and PP14) and 6-
to 20-fold (galectin-1). MQ, Millipore Q water.T
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Molecules with Immunomodulatory Potential
Galectin-1 and Core 2  -1,6-N-acetylglucosaminyl Trans-
ferase (C2GNT).  Although galectin-1 is expressed by all
NK cell types, its transcription level is greatly elevated in
dNK cells relative to the other two subsets (Fig. 3 B), a result
that was confirmed by RT-PCR (Fig. 5). Galectin-1 is a
member of a small family of carbohydrate-binding proteins
(galectins 1–14; reference 55). Although galectins recog-
nize N-acetyl-lactosamine (galactosyl-N-acetylglucosamine),
they have a higher affinity for polylactosamine moieties
present in N-glycosylated and core 2 O-glycosylated glyco-
proteins. Two enzymes are essential for the presence of these
moieties on N- or O-glycan structures. For N-glycans,
Mgat 5 initiates a fourth branch to form a tetraantenary gly-
can, which is elongated with polylactosamine groups. For
O-glycans, C2GNT initiates a second branch (core 2) on
O-glycans that is also further elongated with polylactosa-
mine residues (56, 57). Divalent galectin-1 homodimers
binding to cell surface O- and N-glycosylated glycoproteins
mediate cell–cell interactions, and generate lattices that can
segregate, group, or affect clustering of cell surface glycopro-
teins (57). Microarray expression profiles show that Mgat5 is
not expressed on any of the three subsets of NK cells studied
here. Strikingly, however, C2GNT required for core 2
O-glycan synthesis is expressed on dNK cells but on neither
of the two subsets of pNK cells (Fig. 3 B).
Galectins have been implicated in immune maturation
and modulation through various mechanisms (55). Mgat5
expression in T cells negatively regulates T cell activation
and autoimmunity. Galectin binding restricts TCR recruit-
ment to the synapse by formation of a lattice resulting from
its binding to tetraantennary N-glycosylated glycoproteins
(58). Most recently, galectin-1 has been implicated in pre–B
cell and bone marrow stromal cell synapse formation as a
stromal cell ligand of the pre–B cell receptor (59). Core 2
O-glycans are expressed by CD4   CD8   T cells in a
regulated manner during intrathymic maturation (56). Ga-
lectin-1 mediates thymocyte binding to stromal cells. It also
induces apoptosis of immature CD8low CD4low thymocytes
and peripheral activated T cells through galectin-1–medi-
ated segregation of O-glycosylated CD45 from CD7 and
CD43. This process is dependent on C2GNT expression
(57, 60). Other effects of galectin-1 on T cells have been
reported previously (55). Two hypotheses are suggested by
these data as follows: (a) galectin-1 and C2GNT, the en-
zyme required to initiate formation of its ligand, are ex-
pressed by NK cells in the decidua because they are needed
to down-modulate cytotoxic activity; and (b) galectin-1
present on trophoblasts in the placental bed (61) may origi-
nate from dNK cells and may function on the trophoblast
to down-modulate cytotoxicity.
PP14 (Also Called GdA, Glycodelin A).  PP14 was uniquely
expressed in dNK cells (Fig. 5). Although its expression
level was variable (Fig. 5) and, therefore, did not reach the
statistical significance level required for inclusion in Fig. 3,
it was present and highly expressed in seven of the nine
dNK samples but in neither of the pNK cell subsets. Its dif-
ferential expression was confirmed by RT-PCR. PP14 is a
28-kD glycoprotein with a unique carbohydrate configuration
that is very unusual in mammals. Although it was first isolated
from human placenta, it was later shown to be synthesized by
endometrial glands and gestational deciduas, with the highest
production at 10–14 wk of gestation (62). PP14 has been re-
ported to inhibit T lymphocyte proliferative responses and to
negatively regulate T cells by localizing to the APC–T cell
contact site and elevating activation thresholds (63). It was also
reported to inhibit K562 lysis by pNK cells (64).
Granzymes and Perforin 
Granularity is a characteristic of both dNK and CD56dim
pNK cells, both of which are also called large granular lym-
phocytes (65), whereas CD56bright pNK cells are known to
be less granular (15). Granzyme B and perforin (components
of cytotoxic granules) were expressed at similar levels in
dNK and CD56dim pNK cells, whereas granzyme A was 3-
and 10-fold overexpressed in dNK cells versus the CD56dim
and CD56bright pNK cells, respectively (Fig. 3 C). Thus, the
potential cytolytic function of dNK cells, probably regu-
lated, cannot be ignored. This nascent activity could be
manifest in the decidua under special circumstances (e.g.,
virus infection of the trophoblast or decidual remodeling).
Many other genes overexpressed in dNK cells that are
presented in Fig. 3 (e.g., CD31, CD38, MIP-1  / , Syk,
LEF1, AARS, arp2/3 subunit, and tubulins) may be of
considerable interest but are beyond the scope of the
present paper. Likewise, genes that are absent or have
lower expression in dNK cells in relation to pNK cells may
be relevant to dNK or pNK cell function and interesting
candidates for further study. For instance, toll-like receptor
1 (Fig. 3 A) and SH2D1A (Fig. S1 A) are expressed in both
pNK subsets but not in dNK cells. CD6 is expressed only
in CD56dim pNK cells, whereas the receptor activator of
NF- B, a new member of the TNF superfamily of recep-
tors, transcripts are found only in CD56bright pNK cells (Fig.
3 A). Both may be relevant to interactions between these
and other cells (66, 67). Finally, functions other than a role
in fetal-maternal tolerance have been suggested for dNK
cells. In particular, roles for them in placental development
and in vascular remodeling of uterine spiral arteries have
been suggested in the mouse (11, 66, 67). dNK cells may
have different functions in response to novel ligands in dis-
tinct uterine microenvironments. The data presented in
Fig. S1, as well as that included in Fig. 3 (A–C), should be
particularly useful to those interested in these and other
phenomena associated with pregnancy.
It is worthwhile to ask whether the overexpression of a
large number of genes in dNK cells may have been due to
activation by the procedure used to isolate them (i.e., dis-
aggregation with collagenase and DNase, incubation to al-
low adhesion of stromal cells and macrophages to plastic
and Ficoll density gradient separation, a procedure requir-
ing 4–6 h [Materials and Methods]). The procedure has
been applied previously to isolate lymphocytes from other
organs such as pancreas, liver, and intestines without ap-
parent activating effects. Nevertheless, pNK cells were putT
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through a mock isolation procedure and the markers that
distinguished dNK cells from their blood counterparts
were analyzed. The mock isolation was performed with
and without the addition of human decidual stroma.
FACS® and PCR analysis of the most relevant markers
(Figs. 3–5; CD69, a marker for activation; CD9, a charac-
teristic marker of dNK cells as shown in this paper; CD16,
a specific marker of CD56dim pNK cells; and PP14, a pro-
tein exclusively expressed by dNK cells) was performed.
No changes in the expression of these markers on CD56dim
or CD56bright pNK cells were observed when the isolation
procedure was performed in the absence or in the presence
of decidual stroma (Fig. S2 available at http://www.jem.org/
cgi/content/full/jem.20030305/DC1). Nevertheless, it can-
not be excluded that changes in a fraction of the 197 up-
regulated genes in dNK cells may have been the result of
activation during the isolation procedure.
The present paper has provided a detailed characteriza-
tion of gene expression in the different NK cell subsets
present in peripheral blood and early pregnancy decidual tis-
sues. First, dNK cells are remarkably different from either
subset of pNK cells; CD56bright pNK cells are far more simi-
lar to the CD56dim pNK cell subsets than they are to the
CD56bright dNK cells. Second, the majority of differentially
expressed genes are overexpressed by dNK cells. In contrast,
the relatively small number of differentially expressed genes
in the pNK cell comparison are equally distributed between
those that were overexpressed in CD56dim versus CD56bright
pNK cells, and those overexpressed in CD56bright versus
CD56dim pNK cells. The observed differences in gene ex-
pression may be explained by two alternative hypotheses as
follows: (a) dNK cells represent a distinct lineage of NK
cells, possibly arising from a distinct hematopoietic precur-
sor; or (b) the differences reflect a maturation of pNK cells
(most likely the CD56bright subset) in the decidual microen-
vironment. Additionally, the nature of the precursors and
sites of differentiation, of dNK cells, and, in particular, the
effect of hormones and decidual stroma (whose effect on
differentiation have been scarcely studied) are of consider-
able interest. Special attention must be paid to general ef-
fects common to many stroma and possible specific effects
that may lead to expression of dNK cell–specific molecules.
Third, and most interestingly, genes that provide exciting
new venues for research were overexpressed in dNK cells.
These include CD9 and other tetraspanins (at least four in-
tegrin subunits: NKG2C and NKG2E, Ly-49L, KIRs, ga-
lectin-1, and PP14), all of which could have immunomodu-
latory functions during pregnancy. The data strongly suggest
a distinct function for dNK cells in pregnancy (i.e., a role in
maternal-fetal tolerance).
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